ET
BSX icon

Equitable Trust’s Boston Scientific BSX Stock Holding History

Equitable Trust’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$513K Sell
12,027
-885
-7% -$48.1K 0.02% 316
2026
Q1 		$810K Buy
+12,912
New +$1.03M 0.04% 248

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Equitable Trust's BSX Position: Q2 2026 in Review

Equitable Trust reduced its Boston Scientific (BSX) stake by 6.9% in Q2 2026, selling an estimated $48.1K and leaving 12,027 shares worth $513K. The position accounts for 0.02% of the portfolio, ranked #316.

Equitable Trust first reported a position in BSX in Q1 2026 and has held it in 2 quarters since. The position peaked at $810K in Q1 2026. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Equitable Trust held 12,027 shares of Boston Scientific worth $513K as of Q2 2026.
  • Equitable Trust sold 885 Boston Scientific shares in Q2 2026, an estimated $48.1K.
  • Boston Scientific made up 0.02% of Equitable Trust's portfolio in Q2 2026, its #316 holding.
  • Equitable Trust first reported a position in Boston Scientific in Q1 2026 and has held it in 2 quarters since.
  • Equitable Trust's Boston Scientific position peaked at $810K in Q1 2026.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Equitable Trust's 13F filing for Q2 2026, filed 23 Jul 2026.